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Abstract: 
Classification trees built with the Classification And Regression Tree algorithm were 
evaluated for modelling infrared spectroscopic data in order to discriminate between genuine 
and counterfeit drug samples and to classify counterfeit samples in different classes following 
the RIVM classification system.  
Models were built for two data sets consisting of the Fourier Transform Infrared spectra, the 
Near Infrared spectra and the Raman spectra for genuine and counterfeit samples of 
respectively Viagra® and Cialis®. 
Easy interpretable models were obtained for both models. The models were validated for 
their descriptive and predictive properties. The predictive properties were evaluated using 
both cross validation as an external validation set. The obtained models for both data sets 
showed a 100% correct classification for the discrimination between genuine and counterfeit 
samples and 83.3% and 100% correct classification for the counterfeit samples for the 
Viagra® and the Cialis® data set respectively. 
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1. Introduction  
 
Due to the extension of the internet, counterfeit drugs represent a growing threat for public 
health in the developing countries but also more and more in the industrial world [1,2].  The 
European Agency for Access to Safe Medicines (EAASM) claims that about 50% of the 
medicines sold through non identified/recognized websites are counterfeit and that 10% of 
the market in the developing countries and about 1% of the European market is covered by 
counterfeits [3]. In Europe and the United States one of the most popular group of medicines 
bought through the internet are the phosphodiesterase type 5 (PDE-5) inhibitors, i.e. 
sildenafil citrate (Viagra®), tadalafil (Cialis®) and vardenafil hydrochloride (Levitra®). 
The World Health Organization (WHO) [4] defines a counterfeit drug as: “one which is 
deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting 
can apply to both branded and generic products and counterfeit products may include 
products with the correct ingredients or with the wrong ingredients, without the active 
ingredients, with insufficient active ingredient or with fake packaging.”  
Even if this is the internationally accepted definition of a counterfeit medicine, it does not 
apply to the majority of the illegal products encountered on the European market, since they 
do not copy the packaging and brand names of the genuine products. Therefore it was 
chosen to follow the classification proposed by the Dutch National Institute for Public Health 
and the Environment (RIVM) [5]. This classification (table 1) distinguishes counterfeits, which 
appearance corresponds to the one of the genuine products, and imitations, which do not. 
Most of these imitations originate from Asia, where European and American patents are not 
recognized. 
 
In literature several analytical techniques were proposed to discriminate between counterfeit 
and genuine medicines. Savaliya et al. proposed to use HPLC and LC-MS for the screening 
of aphrodisiacs on the Indian market [6]. Infrared-spectroscopy showed to be a valuable 
instrument for the identification of counterfeit medicines. Y. Roggo et al. [7] and Vajna et al. 
[8] made use of Raman spectroscopy for the identification of pharmaceutical tablets and 
investigate their structural differences, while de Veij et al. [9] used Raman spectroscopy to 
detect counterfeit Viagra®. Storme-Paris et al. [10], De Peinder et al. [11] Puchert et al. [12] 
and Lopes et al. [13,14] all demonstrated the usefulness of near infrared spectroscopy in the 
distinction of genuine and counterfeit medicines.  Other techniques found for this purpose are 
colorimetry [15,16], TLC [17], NMR [18,19] and X-ray powder diffraction [20]. An overview of 




Table 1: Classification of illegal medicines according to the RIVM [5] 
Main category Subcategory Inclusion and exclusion criteria 
  Professional Appearance in conformity with genuine medicine; 
    Content of correct API within 90 - 110 % of declared value; 
    No other APIs; not genuine medicine. 
  Non-professional Appearance in conformity with genuine medicine; 
    Content of correct API outside 90 - 110 % of declared value; 
    No other APIs. 
Counterfeit Mixed  Appearance in conformity with genuine medicine; 
   Contains correct API and another, known API 
  Fraudulent  Appearance in conformity with genuine medicine; 
    Contains a different, known API. 
  Analogue  Appearance in conformity with genuine medicine, 
    Contains other, unapproved API 
  Placebo Appearance in conformity with genuine medicine; 
    Does not contain APIs. 
  Professional Appearance not in conformity with genuine medicine; 
    Content of correct API within 90 - 110 % of declared value; 
    No other APIs. 
  Non-professional Appearance not in conformity with genuine medicine; 
    Content of declared API outside 90 - 110 % of declared value; 
    No other APIs. 
Imitation Mixed  Appearance not in conformity with genuine medicine; 
   Contains declared API and another API. 
  Fraudulent  Appearance not in conformity with genuine medicine; 
    Contains an undeclared API. 
  Analogue  Appearance not in conformity with genuine medicine; 
    Contains other, unapproved API 
  Placebo Appearance not in conformity with genuine medicine; 
    Does not contain APIs. 
 
One thing all these techniques have in common is that they generate a huge amount of data, 
which is often difficult to interpret in order to see differences between the different samples 
and to determine the cause of the differences. The majority of the authors make use of 
explorative chemometric tools to visualise the differences in the data obtained for the 
different samples: Principal Component Analysis, Partial Least Squares, Projection Pursuit, 
Multiple Factor Analysis and clustering techniques as hierarchical clustering, Generative 
topographic mapping and auto-associative multivariate regression trees are examples of 
methods that were and can be used for such purpose [9,22-24]. Even if some of the applied 
methods could be able to give a model with predictive ability, only a few authors created a 
model able to predict if a sample is counterfeit or not. Storme-Paris et al. [10] applied SIMCA 
to obtain a predictive model. The SIMCA model is a PCA-based model and the interpretation 
of the predictions is not always clear.  
In this paper we evaluated the use of Classification And Regression Trees (CART) to build 
an easily interpretable predictive model to distinguish between counterfeit and genuine 
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medicines and to classify the counterfeit samples based on the RIVM definitions [5]. The first 
aim was to discriminate between genuine and counterfeit samples with at least 0% of 
genuines classified as counterfeits. The secondary aim was to be able to classify the 
counterfeit samples in their respective RIVM classes or at least get an idea about the type of 
the class. 
To do so the data acquired by Sacré et al. [24] was used. The different samples were 
classified, following their visual aspects and the results obtained after identification and 
dosage of the active components, applying the RIVM classification system. The classes were 
used as response variable, while the spectroscopic data (FT-IR, NIR and Raman) were used 
as descriptive variables.   
The results were compared to the results obtained by Sacré et al. [24]. In this paper the 
exploratory chemometric tools PCA and PLS were used for discrimination purposes. The 
results obtained with CART were also compared with the ones obtained with a more classic 
discrimination method, k-nearest neighbours (kNN). Due to the limited number of samples of 
some RIVM classes, SIMCA was not applied, since this will result in non representative 
classification rates for the counterfeit samples. This is due to the fact that in SIMCA each 




2.1. Classification And Regression Trees (CART) 
 
CART is a non-parametric statistical technique, developed by Breiman et al. [25] in 1984, 
which is able to solve classification (categorical dependent variables) as well as regression 
problems (continuous dependent variables). In both cases the method builds a decision tree, 
describing a response variable as a function of different explanatory variables (figure 1).  
all objects 
x1 < a1 
x2 < a2 
x4 < a4 
x3 < a3 
 
Figure 1: General structure of a CART-model. xi = selected split variable, ai = selected split value 
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A CART analysis generally consists of three steps. In a first step the maximum tree is build, 
using a binary split-procedure. The maximum tree is overgrown and closely describes the 
training set, usually resulting in overfitting. In a second step this overfitted model is pruned. 
This procedure results in a series of less complex trees, derived from the maximum tree. In 
the third and final step the optimal tree is selected using a cross validation procedure [25-27]. 
 
2.1.1. Building the maximum tree 
 
The maximum tree is built using a binary split procedure, starting at the tree root, consisting 
of all objects in the training set. In every step of the procedure a mother group is considered 
and split into two daughter groups. The split is chosen in such a way that the impurity of the 
daughter groups is lower than that of the mother group. This means that the daughter groups 
become more homogeneous in the response variable (class numbers). In the following step 
each daughter group is considered a mother group. Every split is defined by one value of one 
explanatory variable. For continuous explanatory variables the splits are defined by “xi < aj” 
where xi is the selected variable and aj its split value [25-27].   
To choose the most appropriate variable and split value, CART uses an algorithm in which all 
descriptors and all possible split values are considered. The split resulting in the highest 
decrease in impurity between the mother group (tp) and the daughter groups (tL and tR) is 
selected. Mathematically this is expressed as: 
 
)()()(),( RRLLppp tiptiptitSi −−=∆                   (eq 1) 
where i is the impurity, S the candidate split value, and pL and pR the fractions of the objects 
in the left and right daughter groups, respectively [25-27]. 
 
For classification trees the impurity can be defined by different split criteria [25]. The three 
commonly used split criteria are the Gini index, the Twoing index and the Information index. 
In this work CART models were built using the Gini index. The Information index and the 
Twoing index were not used since these measures were not found useful in solving the 
considered classification problem. 








2))((1                     (eq 2) 
where j = 1, 2, 3,…, k is the number of classes of the categorical response variable and pj(t) 
the probability of correct classification for class j at node t.  
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2.1.2. Tree pruning 
 
The obtained maximum tree usually overfits the training set, therefore the model is pruned by 
successively cutting terminal branches. This procedure results in a series of smaller sub 
trees derived from the maximum tree. The different sub trees with the same complexity are 
then compared to find the optimal. This comparison is based on a cost-complexity measure 
)(TRα , in which both tree accuracy and complexity are considered [25-27]. For each sub 




αα += )()(                     (eq 3) 
with )(TR  the average within-node sum of squares, T(  the tree complexity, defined as the 
total number of nodes of the sub tree, and α the complexity parameter, which is a penalty for 
each additional terminal node.  
 
During the pruning procedure, α is gradually increased from 0 to 1 and for each value of α, 
the tree is selected which minimizes )(TRα . For a value of α equal to zero, )(TRα  is 
minimized by the maximum tree. By gradually increasing α a series of trees with decreasing 
complexity is obtained [25-27]. 
 
2.1.3. Selection of the optimal tree 
 
From the obtained sequence of sub trees, the optimal has to be selected. The selection is 
usually based on the evaluation of the predictive error of the models using a cross validation 
procedure. In this paper a 10-fold cross validation procedure [26, 28] was used. The 
predictive error is then given as the overall misclassification rate for each of the sub trees 
[25]. The optimal model is the simplest model with a predictive error within one standard 
error (SE) of the minimal predictive error. This rule, generally referred to as the one SE-rule, 
allows the selection of a less complex model than the one with the minimal misclassification 
rate, without a significant loss of information and accuracy [25]. The algorithm allows the 
selection of all tree complexities. If previous knowledge about the data set justifies it, one can 
deviate from the one SE-rule and select another tree as optimal model. 
 
2.2. k Nearest Neighbours (kNN) 
The k-NN algorithm [28] was applied on the training set. The algorithm computes the minimal 
Euclidian distances between an unknown object and each of the objects of the training set. 
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For a training set of n samples, n distances are calculated. Then it selects the k nearest 
objects to the unknown one. The unknown object is classified in the group to which the 
majority of the k objects belong. The number of nearest neighbours is optimised using a 
cross validation procedure. The main advantages of this method are its mathematical 
simplicity and the fact that it is free from statistical assumptions. 
 




The data for the Viagra® like samples consists of the Fourier-transformed infrared, the near-
infrared and the Raman spectra for 55 counterfeit samples and 9 genuine samples. For the 
Cialis® like samples the data consists of the same type of spectra for 39 counterfeit and 4 
genuine samples. All spectra were measured in triplicate. For more details about how this 
data was acquired we refer to Sacré et al. [24]. During the study of Sacré et al. it was seen 
that the variability in spectral data between the genuine samples is very low. The limited 
number of genuine samples should therefore be enough to represent the genuine class in 
the models. The more because CART defines the classes based on the improvement of 
homogeneity from mother to daughter leaves and therefore should isolate the small class of 
genuine relatively early in the building of the tree. 
All counterfeit and imitation samples were donated by the Federal Agency for Medicines and 
Health Products in Belgium (AFMPS/FAGG). One batch of each dosage of genuine Viagra® 
(25mg, 50mg and 100mg) was kindly provided by Pfizer SA/NV (Belgium). Eli Lilly SA/NV 
(Benelux) kindly provided one batch of each commercial packaging (10 mg and 20 mg) of 
genuine Cialis®. Two other batches of each dosage of the genuine products were purchased 
from local pharmacies in Belgium.  
The counterfeit samples were classified following the classification proposed by the RIVM [5]. 











Table 2: Composition of the data sets in function of the RIVM classes [5] 
Main category subcategory category number 
number of Viagra® like 
samples 
number of Cialis® like 
samples 
 Professional 1 1 0 
 Non-professional 2 3 0 
Counterfeit Mixed 3 1 5 
 Fraudulent 4 0 0 
 Analogue 5 0 0 
 Placebo 6 0 0 
 Professional 7 45 27 
 Non-professional 8 4 2 
Imitation Mixed 9 1 5 
 Fraudulent 10 0 0 
 Analogue 11 0 0 
 Placebo 12 0 0 
Genuine 
 0 9 4 
 
 
3.2. Data preprocessing 
 
The data preprocessing was performed using the HoloREACTTM software (Kaiser Optical 
Systems, USA, version 2.3.5). For NIR and FT-IR spectroscopy, the three spectra of a 
sample were normalized and averaged. For Raman spectroscopy, the three spectra of a 
sample were baseline corrected using the Pearson’s method [29]. 
In order to evaluate the predictive ability of the models the Viagra® and Cialis® data sets were 
divided in training and test sets. It was chosen that the test sets would contain about 20% of 
the samples. The division in test- and training set was performed using the Duplexx algorithm 
[30]. This algorithm starts by selecting the two samples with the highest Euclidean distance 
in the data space for a first set. The next two samples with the highest Euclidean distance 
are selected for a second set. The procedure continues by selecting iteratively pairs of 
samples for the first and the second set. The second set was chosen as test set, while the 
other set combined with the samples not selected by the algorithm formed the training set. 
During selection of the test sets it was made sure that one genuine sample was selected for 
the test set, while the others were kept in the training set. This was necessary due to the 
limited number of genuine samples in the data sets. 
From the PCA plots [31] shown in figure 2 and 3 it can be seen that the test sets selected by 






Figure 2: PCA plots representing the spread of the test set for the Viagra® data set over the data space. 




The data preprocessing and the modelling was performed using Matlab R2009b (The 
Mathworks, Natick, USA). The programming of the CART algorithm was done according to 
the original CART algorithm proposed by Breiman [25]. 
 
4. Results and Discussion 
 
4.1. Viagra® like samples 
 
For all data sets used the data was first autoscaled. The signals at the different wavelengths 
in the respective spectra were used as explanatory variables while the class numbers of the 
different samples were used as response. The class numbers were assigned to the different 


















































The maximal tree was built and pruned. In a next step a 10-fold cross validation was carried 
out resulting in a graph representing the percentage misclassification as a function of the tree 
complexity. 
 
4.1.1. Classification tree based on the FT-IR data 
 
Figure 4 shows the graph of the percentage misclassification as a function of the tree 
complexity obtained with the FT-IR data. As can be seen from the figure the tree with 
complexity 2 has the smallest cross validation error. Since we have more than two classes 
and following the general rule that the optimal tree can have each complexity with a cross 
validation error within one standard deviation of the tree with the smallest error, the tree with 
complexity five was selected as optimal tree (figure 5). The cross validation error was 0.26 or 
11.6%. Even if the cross validation error is quite high, it could be observed that during cross 
validation all genuine samples were classified correctly and none of the counterfeit or 
imitation samples were classified as genuine. This was confirmed during external validation, 
which means that the CART model is able to distinguish between genuine and counterfeit 
drugs, based on the FT-IR data. When focussing on the classification of the counterfeit or 
imitation samples over the different classes it was observed that 10 of the 12 counterfeit 
samples of the external test set were classified correctly while the 2 other were classified as 
non-professional imitations (class 8) in stead of professional imitations (class 7).  Since the 
data set of the Viagra® like samples contains representatives of 7 classes, one should select 
a tree with minimal 7 leafs in order to be able to predict each class. Since our primary goal 
was to distinguish between counterfeit and genuine and the fact that we chose the optimal 
tree size based on the cross validation results, the leafs of the selected tree are not 
homogeneous for some counterfeit classes (class 1,3,9) and so the tree model is only able to 
give an indication about the sample type for these samples. The inhomogeneity for these 
classes in the model is probably due to the low number of samples belonging to these 











Figure 4: the cross validation error and the resubstitution error in function of the tree complexity for the FT-IR 
data 
Figure 5: Classification tree based on the FT-IR data for the Viagra® data set. Each split is defined by the 
selected wavelength and its splitvalue. Each leaf is defined by the class number of the class most represented in 
the leaf and the graph gives the distribution (homogeneity) of the different samples in the leaf.  
 
One of the main disadvantages of CART, used with spectral data is that it selects only one 
variable/wavelength to define each split. Since spectral data usually has a signal over a 
range of wavelengths this causes the difficulty to interpret the significance of the selected 
wavelengths. In fact for the CART model based on the FT-IR data the wavelengths of 886 
cm-1 and 1700 cm-1 could be related to the concentration of sildenafil present in the samples. 
For the other selected wavelengths no logical explanation could be found.    
 

































1 std error 
Crossvalidation error 
Resubstitution error 
886 < 0.36786  
1700 < 0.55295  
556 < 0.28260 
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4.1.2. Classification tree based on the NIR data 
 
From a similar graph as shown in figure 4 it could be concluded that for the NIR data, the 
tree with complexity 4 has the lowest cross validation error and is the optimal tree (figure 6). 
The cross validation error was 0.37 or 14.4 %. Investigation of the tree shows that the leaf of 
the genuine samples is homogeneous and that during cross validation all genuine samples 
were classified correctly and that none of the counterfeit samples was classified as genuine.  
These results were also reflected during the external validation. During external validation, 
ten of the twelve counterfeit samples were classified correctly, while two professional 
imitations (class 7) were classified as non-professional counterfeits. From these results it can 
be concluded that the CART model based on NIR-data is comparable to the model obtained 
with the FT-IR data for its predictive and descriptive properties.  
Figure 6: classification tree based on the NIR data for the Viagra® data set. Each split is defined by the selected 
wavelength and its splitvalue. Each leaf is defined by the class number of the class most represented in the leaf 
and the graph gives the distribution (homogeneity) of the different samples in the leaf.  
 
Investigation of the selected variables revealed that the selected wavelengths 4150.1 cm-1 
and 5233.9 cm-1 correspond to specific peaks of the NIR spectrum of microcrystalline 
cellulose. It can therefore be stated that the discrimination of genuine and counterfeit 
samples by the CART model, based on NIR data, is partly based on the presence of different 
amounts of microcrystalline cellulose in the counterfeit and the genuine samples. 
 
4.1.3. Classification tree based on the Raman spectroscopy data 
 
For the Raman spectroscopic data the tree with complexity 3 was selected as the optimal 
tree (figure 7). The cross validation error was 0.25 or 11.5 %. Investigation of the tree and 
4007.4 < 0.72485  
5233.9 < 0.62965 
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the cross validation results show that the leaf representing the genuine samples (0) is 
homogeneous and that no genuine samples are classified in another leaf. Also during cross 
validation all genuine samples are correctly classified and none counterfeit sample is 
classified as genuine. The external validation reflects the same, all genuine are classified as 
genuine and no counterfeits are classified as genuine. When focussing on the classification 
of the counterfeit samples of the external test set, the model gives a correct classification for 
8 of the 12 samples, which is significantly worse compared to the previous 2 models.  
Figure 7: classification tree based on the Raman data for the Viagra® data set. Each split is defined by the 
selected wavelength and its splitvalue. Each leaf is defined by the class number of the class most represented in 
the leaf and the graph gives the distribution (homogeneity) of the different samples in the leaf.  
 
The selected wavelengths could be linked to the presence of excipients. The wavelength of 
501.6 cm-1 is a characteristic signal for the Raman spectrum of calcium hydrogenophosphate 
while 846 cm-1 is a wavelength corresponding to a signal characteristic for 
hydroxypropylcellulose. Calcium hydrogenophosphate is present in the genuine samples, but 
not or in different amounts in the counterfeit samples. Hydroxypropylcellulose on the other 
hand is not present in the genuine samples. Again it can be stated that the discrimination of 
the CART model is based on the presence of secondary components and excipients.  
 
4.1.4. Classification trees based on the combination of the spectral data 
 
Tree models were built using combinations of the data. One model was built using the FT-IR 
and the NIR data, one using the FT-IR and the Raman data, one using NIR and Raman and 
one using the combination of the three. 




846 < 0.11327 
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The models obtained with the combination of the FT-IR and the NIR data as well as the one 
based on the three types of spectral data, did not result in a satisfying model since a number 
of counterfeit samples was classified as genuine during both cross validation as external 
validation. Since the models based on each technique separately were able to make this 
distinction, it seems that combining the two data sets introduces noise in the model.  
The other two models (combination of FT-IR and Raman and NIR and Raman respectively) 
were able to distinguish counterfeit from genuine samples, since no genuine sample were 
classified as counterfeit and no counterfeit as genuine, during both cross validation as 
external validation. During external validation it was seen that the models had higher 
misclassification rates (4/12 and 5/12) than the models discussed in section 4.1.1 and 4.1.2. 
From these results it has to be concluded that the combination of different types of spectral 
data, does not result in better models for the Viagra® data set. 
 
4.2. Cialis® like samples 
 
Exactly the same approach as described for the Viagra® data set was followed. The 
assignment of the class numbers, based on the RIVM classification, for the Cialis® data set is 
given in table 2. 
 
4.2.1. Classification trees based on the FT-IR and the NIR data 
 
From the graphs of percentage misclassification in function of the tree complexity the trees of 
complexity three and five were selected as optimal trees for respectively the FT-IR and the 
NIR data. Since cross validation and external validation showed that both models were not 
able to distinguish between genuine and counterfeit samples, these models are not further 
discussed. 
  
4.2.2. Classification tree based on the Raman spectroscopy data 
 
The tree of complexity five was selected as the optimal model obtained using the Raman 
spectroscopy data for the Cialis® data set (figure 8). A cross validation error of 0.62 or 28 % 
was obtained, which is high if it is compared to the errors obtained for the models for the 
Viagra® data set. Investigation of the leafs shows that the group of the genuine samples is 
homogeneous and that no genuine is classified with counterfeit samples. Also during cross 
validation all genuine samples are correctly classified and no counterfeit samples are 
classified as genuine. During external validation on the other hand it could be observed that 
 15 
despite the fact that all genuine samples are correctly classified, two counterfeit samples are 
wrongly classified from which one is classified as genuine. 
 
Three of the selected wavelengths (1109.1 cm-1, 1119.0 cm-1 and 1120.2 cm-1) could be 
linked to the Raman spectrum of lactose, an excipient present in both genuine as counterfeit 
samples. Probably the differences in amounts partly account for the discrimination. 
Figure 8: classification tree based on the Raman data for the Cialis® data set. Each split is defined by the 
selected wavelength and its splitvalue. Each leaf is defined by the class number of the class most represented in 
the leaf and the graph gives the distribution (homogeneity) of the different samples in the leaf.  
 
4.2.3. Classification trees based on the combination of the spectral data 
 
Tree models were built using a combination of the different types of spectral data. The only 
model able to distinguish between counterfeit and genuine samples was the one combining 
the NIR and the Raman spectroscopic data. The tree with complexity six was selected as the 
optimal tree (Figure 9). A cross validation error of 0.50 or 22.5 % was obtained. Investigation 
of the leafs showed that the leaf representing the genuine samples is homogeneous and that 
no genuine samples are classified with counterfeit ones. Also during cross validation and 
external validation all genuine are classified correctly and no counterfeit samples are 
classified as genuine. It has also to be mentioned that during external validation all 
counterfeit samples were classified correctly. 
Three of the selected NIR wavelengths (4215.6 cm-1, 5997.5 cm-1 and 6730.3 cm-1) could be 
linked to excipients, present in the genuine Cialis® tablets. 4215.6 cm-1 corresponds to a 
characteristic peak of lactose, 5997.5 cm-1 to a characteristic peak of carmellose and 6730.3 
cm-1 to one of microcrystalline cellulose. The two other wavelengths could not be linked to 
compounds, present or not in counterfeit samples.  
1109.1 < 0.26207 
 
1113.6 < 0.38867  
1120.2 < 0.48796 
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Since three of the five wavelengths could be linked to excipients present in the genuine 
tablets, the discrimination is again probably due to the differences in amounts.  
Figure 9: classification tree based on the combination of the NIR and the Raman data for the Cialis® data set. 
Each split is defined by the selected wavelength and its splitvalue. Each leaf is defined by the class number of the 
class most represented in the leaf and the graph gives the distribution (homogeneity) of the different samples in 
the leaf.  
 
4.3. Results obtained with kNN 
 
kNN was applied to the same data sets as described in sections 4.1 and 4.2. In a first step 
the optimal number of nearest neighbours was chosen, for each data set, using a leave-one-
out cross validation procedure. The models were evaluated based on the correct 
classification rate (CCR) obtained during cross validation and the prediction of the external 
test set. 
Two kind of kNN models were built, one using only the classes 0 for genuine samples and 1 
for counterfeit samples and one using the different classes as used for the CART models. 
The reason is the fact that the theory of the algorithms (CART and kNN) are completely 
different. While CART will isolate the genuine group in a early phase of the model building 
and continue further classification of the counterfeits without influence of the genuine group, 
kNN will model the data set as a whole, resulting in a higher influence of the unbalanced 
numbers of samples in the different classes.    
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4215.6 < 0.12132  
3999.5 < 0.84366  
5997.5 < 0.88958 
 
1113.0 < 040383 
 
 
6730.3 < 0.40001 
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For the Viagra® dataset CCR values of 0.90 (optimal number of k = 3), 1.00 (optimal number 
of k = 3) and 0.9804 (optimal number of k = 3) were obtained for respectively the FT-IR, the 
NIR- and the Raman data, using cross validation when using the binary class (genuine vs. 
counterfeit) approach. Only the model based on the NIR data was able to discriminate 
between genuine and counterfeit, which was reflected by the 100 % CCR for both cross 
validation as external validation. In the models based on the FT-IR data and the Raman data 
at least one genuine was classified as counterfeit, which is unacceptable since it is a false 
positive. When using the different RIVM classes CCR values of 0.55 (optimal number of k = 
5), 0.61 (optimal number of k = 5) and 0.43 (optimal number of k = 9) were obtained for 
respectively the FT-IR, the NIR- and the Raman data, using cross validation. For the external 
validation CCR values were obtained of 0.31, 0.23 and 0.23 respectively. The more in all 
models some originals were classified as counterfeit and some counterfeits as original. 
For the Cialis® dataset it was not possible to discriminate between original and counterfeit 
samples using kNN. Probably due to the fact that the number of genuine samples in this data 
set is too low for the algorithm.  
 
5. Conclusions  
 
The use of classification trees as easy interpretable models for the distinction of counterfeit 
and genuine drugs as well as the classification of counterfeit drugs, following the RIVM 
classification, was evaluated. All models were based on spectroscopic data. Models were 
built for two data sets, one consisting of the spectroscopic data for genuine and counterfeit 
samples of Viagra® and one consisting of the spectroscopic data for genuine and counterfeit 
samples of Cialis®. An overview of the obtained correct classification rates for the different 
models proposed is given in table 3. Only models with a 100% correct classification rate for 
the discrimination between genuine and counterfeit, during cross validation, are present in 
the table, since only these models are of interest.  
 
For the Viagra® data set, two comparable models could be proposed, one based on the FT-
IR data and one on the NIR data. The models have cross validation errors of 11.6% and 
14.4% respectively and equal misclassification rates of 2/12 after external validation. Since 
both models are comparable the choice is based on the equipment present in the 
laboratories. For the both models the classification/discrimination could partly be explained 
by the differences in amounts of active substance (FT-IR model) and excipients (NIR model). 
The combination of the different types of spectroscopic data did not result in better models 
compared to the ones obtained with only FT-IR or NIR data. 
 
 18 
Table 3: Overview of the prediction errors of the proposed models 
 Data used 
CCR genuine/counterfeit 
(cross-validation) (%) 








samples FT-IR 100 88,4 13/13 11/13 
 NIR 100 85,6 13/13 11/13 
 Raman 100 88,5 13/13 9/13 
      
Cialis® like 
samples Raman 100 72 8/9 6/9 
 Raman-NIR 100 77,5 9/9 9/9 
 
For the Cialis® data set the best model was obtained by combining the NIR and the Raman 
spectroscopic data. All other models were not able to make the distinction between 
counterfeit and genuine samples. Only the model based on the Raman spectroscopy data 
was able to classify all genuine samples correctly, but also classified a counterfeit sample as 
genuine. 
The proposed model has a cross validation error of 22.5%, but showed a 100% correct 
classification during external validation. Again the majority of the selected wavelengths could 
be linked to differences in amounts of excipients between the different samples.  
The obtained results show that the application of CART to spectroscopic data result in easy 
interpretable models, which are able to discriminate between counterfeit and genuine drug 
samples and which are able to classify the counterfeit samples in their corresponding RIVM 
class and this with low misclassification rates, evaluated with an external test set. The 
classification of the counterfeits in their respective RIVM class, can allow an easy and fast 
evaluation of the risk for public health of a considered counterfeit sample. 
Further it was shown that the results obtained with this tree based method are far better than 
the ones obtained with the more traditional discriminating method kNN. If the results of the 
CART models are compared to the results obtained with PLS by Sacré et al. [24], it can be 
seen that both methods are able to discriminate between genuine and counterfeit products, 
but that CART also allow a clear discrimination of the counterfeit samples in different 
classes. The more CART has the advantage to be able to classify the samples in a 
discriminating and easy interpretable model. Though the models are limited by the nature of 
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